An observational study in Healhty, sponsored by Istanbul Gedik University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-30.
Sponsored by Istanbul Gedik University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Balance is the ability of an individual to maintain posture against gravity and sustain stability during movement; it depends on the coordinated functioning of the proprioceptive, visual, and vestibular systems, as well as the central nervous system. Current studies show that movement control occurs not only through the motor system but also through the interaction of sensory-cognitive-motor components. Cognitive functions encompass processes such as attention, memory, visuospatial skills, and executive functions, with attention and visuospatial processing playing a particularly important role in balance control. The literature reports significant relationships between balance and cognitive functions, particularly noting that increased attention requirements in dual-tasking situations negatively impact balance performance. Furthermore, it has been shown that both balance performance and cognitive functions are affected by circadian rhythm and chronotype, with individuals exhibiting different performance levels at different times of the day. Despite this, studies examining the relationship between balance and cognitive functions appear to have insufficiently addressed the chronotype factor. Therefore, the aim of this study is to investigate how the relationship between balance and cognitive functions changes according to individuals' chronotypes.
Istanbul Gedik University is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Healty young people
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Chronotype
It will be assessed by survey (Horne Ostberg). The survey contains a total of 19 questions. Points will be added up based on participants' answers to obtain a score between 16 and 86. 16-30 will be considered evening type, and 70-86 will be considered morning type.
Time frame: baseline - 2 weeks later
balance
It will be assessed with KoreBalance balance system. Users will be asked to keep their eyes open while maintaining a center of gravity on an electronic device. Results are presented as point scores.
Time frame: baseline - 2 weeks later
Attention measurement
It will be assessed with stroop test. Individuals will be tested at a desk. They will first be asked to read only the text written in three different colors. Then they will be asked to read the colors of the text. The total score will be recorded in milliseconds.
Time frame: baseline - 2 weeks later
Visuo-spatial attention
It will be assessed with Flanker task. Eriksen Flanker Task is a classic cognitive psychology test that measures selective attention and response inhibition. You are asked to identify the direction of a central target (e.g., an arrow) while ignoring distracting "flanker" arrows on either side, which can either point the same way (congruent) or opposite (incongruent). The total correct responses are kept.
Time frame: baseline - 2 weeks later
Ran from Aug 2026 to primary completion in Sep 2026, 1 month.
Completion moved once since we started tracking on Sep 25, 2026: Sep 2026 → Oct 2026, on Oct 14, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Istanbul Gedik University